PCN Insights, News, Videos, and More

Massachusetts General Hospital recently announced the opening of a new program to study the use of psychedelics to treat mental illnesses, including depression, anxiety and PTSD.

Less green space surrounding a child’s home may be associated with a higher risk of developing attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Environmental Health Perspectives.

Positive and Negative Syndrome Scale total scores dropped an additional 11.6 points in patients with schizophrenia who received combination xanomeline-trospium, compared with placebo, according to a published study.

During the COVID-19 pandemic, a month of empathy-focused telephone calls from quickly trained laypeople eased depression, anxiety, and loneliness and improved general mental health in Meals on Wheels recipients.

Metabolic syndrome, diabetes, and hypertension are linked with greater global cognitive impairment in people with schizophrenia, according to a systematic review and meta-analysis published online ahead of print in JAMA Psychiatry.

The anticonvulsant ezogabine, also known as retigabine, may offer a new approach to the treatment of depression and anhedonia, suggests a trial published online ahead of print in The American Journal of Psychiatry.

Switching to aripiprazole or ziprasidone could improve weight and other cardiometabolic outcomes in patients with serious mental illness, according to a systematic review and meta-analysis published online in Schizophrenia Bulletin.